Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc, 11329-11330 [2021-03760]

Download as PDF 11329 Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices Registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW 8701 Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket No. DEA–794 in all correspondence, including attachments. SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted. The applicant plans to manufacture bulk active pharmaceutical ingredients (APIs) for product development and distribution to DEA-registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities DATES: specifically authorized by DEA regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place. As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the manner described in the rule published at 85 FR 82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR part 1318. In accordance with 21 CFR 1301.33(a), DEA is providing notice that on January 25, 2021, GGGYI LLC, 4168 South Drexel Boulevard 2A, Chicago, Illinois 60653, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: Controlled substance Drug code Marihuana Extract ................... Marihuana ............................... Tetrahydrocannabinols ........... 7350 7360 7370 Schedule I I I William T. McDermott, Assistant Administrator. [FR Doc. 2021–03754 Filed 2–23–21; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–770] Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Sigma Aldrich Research Biochemicals, Inc, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. Such persons may also file a written request for a hearing on the application on or before April 26, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUMMARY: In accordance with 21 CFR 1301.33(a), this is notice that on December 17, 2020, Sigma Aldrich Research Biochemicals, Inc, 400–600 Summit Drive, Burlington, Massachusetts 01803, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: khammond on DSKJM1Z7X2PROD with NOTICES Controlled substance Drug code Cathinone ........................................................................................................................................................................ 4-Methyl-N-Methylcathinone ............................................................................................................................................ Methaqualone .................................................................................................................................................................. JWH-018 & AM678 .......................................................................................................................................................... Lysergic Acid Diethylamide ............................................................................................................................................. Tetrahydrocannabinols .................................................................................................................................................... Mescaline ......................................................................................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ Alpha-Methyltryptamine ................................................................................................................................................... Dimethyltryptamine .......................................................................................................................................................... 5-Methoxy-N,N-Diisopropyltryptamine ............................................................................................................................. 1-Benzylpiperazine .......................................................................................................................................................... 2-(2,5-Dimethoxyphenyl) Ethanamine ............................................................................................................................. 3,4-Methylenedioxypyrovalerone ..................................................................................................................................... 3,4-Methylenedioxy-N-Methylcathinone .......................................................................................................................... Heroin .............................................................................................................................................................................. Normorphine .................................................................................................................................................................... Norlevorphanol ................................................................................................................................................................ Amphetamine ................................................................................................................................................................... Methylphenidate .............................................................................................................................................................. Nabilone ........................................................................................................................................................................... Phencyclidine ................................................................................................................................................................... Cocaine ............................................................................................................................................................................ VerDate Sep<11>2014 17:21 Feb 23, 2021 Jkt 253001 PO 00000 Frm 00113 Fmt 4703 Sfmt 4703 E:\FR\FM\24FEN1.SGM 24FEN1 1235 1248 2565 7118 7315 7370 7381 7405 7432 7435 7439 7493 7517 7535 7540 9200 9313 9634 1100 1724 7379 7471 9041 Schedule I I I I I I I I I I I I I I I I I I II II II II II 11330 Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices Controlled substance Drug code Codeine ........................................................................................................................................................................... Ecgonine .......................................................................................................................................................................... Levorphanol ..................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Methadone ....................................................................................................................................................................... Morphine .......................................................................................................................................................................... Thebaine .......................................................................................................................................................................... Levo-Alphacetylmethadol (LAAM) ................................................................................................................................... Noroxymorphone ............................................................................................................................................................. Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... Carfentanil ....................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... The company plans to manufacture reference standards. William T. McDermott, Assistant Administrator. [FR Doc. 2021–03760 Filed 2–23–21; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–796] Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Livwell Michigan, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW 8701 Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket No. DEA–796 in all correspondence, including attachments. SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) prohibits the cultivation and khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:21 Feb 23, 2021 Jkt 253001 distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted. The applicant plans to manufacture bulk active pharmaceutical ingredients (APIs) for product development and distribution to DEA-registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities specifically authorized by DEA regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place. As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the manner described in the rule published at 85 FR 82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR part 1318. In accordance with 21 CFR 1301.33(a), DEA is providing notice that on January 25, 2021, Livwell Michigan, LLC, 21550 Hoover Road, Warren, Michigan 48089, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: PO 00000 Frm 00114 Fmt 4703 Sfmt 4703 Controlled substance Marihuana Extract ................... Marihuana ............................... Tetrahydrocannabinols ........... 9050 9180 9220 9230 9250 9300 9333 9648 9668 9739 9740 9743 9801 Schedule II II II II II II II II II II II II II Drug code 7350 7360 7370 Schedule I I I William T. McDermott, Assistant Administrator. [FR Doc. 2021–03759 Filed 2–23–21; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–792] Bulk Manufacturer of Controlled Substances Application: Synthcon LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Synthcon LLC, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. Such persons may also file a written request for a hearing on the application on or before April 26, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on January 5, 2021, Synthcon LLC., 770 Wooten Road, Suite 101, Colorado Springs, Colorado 80915– 3538, applied to be registered as a bulk SUMMARY: E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 86, Number 35 (Wednesday, February 24, 2021)]
[Notices]
[Pages 11329-11330]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03760]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-770]


Bulk Manufacturer of Controlled Substances Application: Sigma 
Aldrich Research Biochemicals, Inc

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Sigma Aldrich Research Biochemicals, Inc, has applied to be 
registered as a bulk manufacturer of basic class(es) of controlled 
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before April 26, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before April 26, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on December 17, 2020, Sigma Aldrich Research 
Biochemicals, Inc, 400-600 Summit Drive, Burlington, Massachusetts 
01803, applied to be registered as a bulk manufacturer of the following 
basic classes of controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Cathinone..........................            1235  I
4-Methyl-N-Methylcathinone.........            1248  I
Methaqualone.......................            2565  I
JWH-018 & AM678....................            7118  I
Lysergic Acid Diethylamide.........            7315  I
Tetrahydrocannabinols..............            7370  I
Mescaline..........................            7381  I
3,4-Methylenedioxymethamphetamine..            7405  I
Alpha-Methyltryptamine.............            7432  I
Dimethyltryptamine.................            7435  I
5-Methoxy-N,N-Diisopropyltryptamine            7439  I
1-Benzylpiperazine.................            7493  I
2-(2,5-Dimethoxyphenyl) Ethanamine.            7517  I
3,4-Methylenedioxypyrovalerone.....            7535  I
3,4-Methylenedioxy-N-                          7540  I
 Methylcathinone.
Heroin.............................            9200  I
Normorphine........................            9313  I
Norlevorphanol.....................            9634  I
Amphetamine........................            1100  II
Methylphenidate....................            1724  II
Nabilone...........................            7379  II
Phencyclidine......................            7471  II
Cocaine............................            9041  II

[[Page 11330]]

 
Codeine............................            9050  II
Ecgonine...........................            9180  II
Levorphanol........................            9220  II
Meperidine.........................            9230  II
Methadone..........................            9250  II
Morphine...........................            9300  II
Thebaine...........................            9333  II
Levo-Alphacetylmethadol (LAAM).....            9648  II
Noroxymorphone.....................            9668  II
Remifentanil.......................            9739  II
Sufentanil.........................            9740  II
Carfentanil........................            9743  II
Fentanyl...........................            9801  II
------------------------------------------------------------------------

    The company plans to manufacture reference standards.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-03760 Filed 2-23-21; 8:45 am]
BILLING CODE 4410-09-P